Hawkins’ (HWKN) “Buy” Rating Reiterated at BWS Financial

BWS Financial reaffirmed their buy rating on shares of Hawkins (NASDAQ:HWKNFree Report) in a report published on Thursday,Benzinga reports. BWS Financial currently has a $160.00 price target on the specialty chemicals company’s stock.

Separately, CJS Securities began coverage on shares of Hawkins in a research note on Tuesday, April 1st. They set a “market outperform” rating and a $125.00 target price on the stock.

View Our Latest Stock Analysis on HWKN

Hawkins Price Performance

Shares of HWKN opened at $122.68 on Thursday. The business’s 50-day moving average is $114.35 and its two-hundred day moving average is $117.07. The company has a market capitalization of $2.57 billion, a P/E ratio of 31.30, a P/E/G ratio of 3.80 and a beta of 0.87. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.53 and a current ratio of 2.50. Hawkins has a fifty-two week low of $83.88 and a fifty-two week high of $139.55.

Hawkins (NASDAQ:HWKNGet Free Report) last posted its earnings results on Wednesday, May 14th. The specialty chemicals company reported $0.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.74 by $0.04. Hawkins had a net margin of 8.60% and a return on equity of 18.95%. The business had revenue of $245.32 million for the quarter, compared to analyst estimates of $230.69 million. Research analysts predict that Hawkins will post 4 earnings per share for the current year.

Hawkins Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 30th will be paid a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.59%. The ex-dividend date of this dividend is Friday, May 30th. Hawkins’s payout ratio is currently 18.37%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of HWKN. Barclays PLC lifted its stake in Hawkins by 180.1% in the 3rd quarter. Barclays PLC now owns 39,728 shares of the specialty chemicals company’s stock valued at $5,064,000 after buying an additional 25,545 shares in the last quarter. Franklin Resources Inc. lifted its stake in Hawkins by 5.8% in the 3rd quarter. Franklin Resources Inc. now owns 19,978 shares of the specialty chemicals company’s stock valued at $2,597,000 after buying an additional 1,100 shares in the last quarter. Annex Advisory Services LLC lifted its stake in Hawkins by 47.5% in the 4th quarter. Annex Advisory Services LLC now owns 20,448 shares of the specialty chemicals company’s stock valued at $2,508,000 after buying an additional 6,587 shares in the last quarter. Ellsworth Advisors LLC lifted its stake in Hawkins by 2.5% in the 4th quarter. Ellsworth Advisors LLC now owns 7,747 shares of the specialty chemicals company’s stock valued at $950,000 after buying an additional 187 shares in the last quarter. Finally, Linden Thomas Advisory Services LLC lifted its stake in Hawkins by 16.0% in the 4th quarter. Linden Thomas Advisory Services LLC now owns 12,729 shares of the specialty chemicals company’s stock valued at $1,561,000 after buying an additional 1,756 shares in the last quarter. 69.71% of the stock is owned by hedge funds and other institutional investors.

Hawkins Company Profile

(Get Free Report)

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.

Featured Stories

Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.